Ursprung des Netzwerks ersten Grades von John Durham
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Intelgenx Corp.
 Intelgenx Corp. Pharmaceuticals: MajorHealth Technology Intelgenx Corp. develops oral-controlled release pharmaceutical products. The firm offers pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. The company was founded in 2003 and is headquartered in Saint-Laurent, Canada.
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von John Durham
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| RBC LIFE SCIENCES, INC. | Pharmaceuticals: Other | Corporate Officer/Principal | |
| PALADIN LABS INC. | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal | |
| NEPTUNE WELLNESS SOLUTIONS INC. | Pharmaceuticals: Other | Chief Executive Officer | |
Conforma Therapeutics Corp.
 Conforma Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Conforma Therapeutics Corp. designs and develops drugs for treatment of cancer. It also develops applications in the areas of medicine, including inflammation, virology and central nervous system disorders. The company was founded in 1999 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Medisyn Technologies, Inc.
 Medisyn Technologies, Inc. Pharmaceuticals: MajorHealth Technology Medisyn Technologies, Inc. develops novel pharmaceuticals, nutraceuticals, and animal health products. The firm engages in the development of pre-qualified proprietary drug compounds. Its Forward Engineering platform is focused on predicting the behavior of molecules from topology. The company was founded in 1999 and is headquartered in Minnetonka, MN. | Pharmaceuticals: Major | Director/Board Member | |
| TETRA BIO-PHARMA INC. | Pharmaceuticals: Other | Corporate Officer/Principal Investor Relations Contact | |
| ACASTI PHARMA INC. | Pharmaceuticals: Major | Chief Executive Officer | |
RBC Capital Partners Ltd.
 RBC Capital Partners Ltd. Investment ManagersFinance RBC Capital Partners Ltd. is a Venture Capital firm, a subsidiary of RBC Dominion Securities, Inc. founded in 1900. RBC Capital Partners Ltd. is headquartered in Toronto, Canada with offices across the globe. | Investment Managers | Private Equity Investor | |
| Concordia University | College/University | Masters Business Admin Undergraduate Degree | |
| University of New Brunswick | College/University | Undergraduate Degree | |
| University of Kiel | College/University | Graduate Degree | |
| University of Montréal | College/University | Doctorate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree | |
Upsher-Smith Laboratories LLC
 Upsher-Smith Laboratories LLC Pharmaceuticals: MajorHealth Technology Upsher-Smith Laboratories, Inc. manufactures generic pharmaceuticals. It serves the pharmacists, physicians, and patients. The firm offers manufacturing, distribution, sales, and marketing services. The company was founded by Frederick Alfred Upsher Smith in 1919 and is headquartered in Maple Grove, MN. | Pharmaceuticals: Major | President | |
| University of Sherbrooke | College/University | Graduate Degree | |
Schwarz Pharma, Inc.
 Schwarz Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCHWARZ PHARMA, Inc. develops and manufactures pharmaceutical products. The company's products include Codimal, Colyte, Edex, Kutrase, Levatol, Robaxin, and Verelan. It was founded in 2003 and is headquartered in Mequon, WI. | Pharmaceuticals: Major | President | |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| INTELGENX TECHNOLOGIES CORP. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer Investor Relations Contact Corporate Officer/Principal Corporate Officer/Principal | |
Canadian Investor Relations Institute
 Canadian Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services The Canadian Investor Relations Institute (CIRI) is a professional organization that aims to enhance the credibility and competency of the investor relations profession. CIRI has four chapters located in different regions. The organization also provides insights on ESG processes and reporting for issuers at various stages in their ESG journey. The non-profit company is based in Oakville, ON, Canada. CIRI provides resources, professional development, networking opportunities, and advocacy to support the IR community. The organization has over 500 members, with most responsible for IR at publicly-traded companies. Visible Alpha is a sponsor of CIRI that enhances the investment research process. CIRI publishes IR Directions, a magazine that explores current and emerging practices of board reporting and engagement. Nathalie Megann has been the CEO of the Canadian company since 2004. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Pharmaceutical Corp. of America | Comptroller/Controller/Auditor | ||
PharmEng Technology, Inc.
 PharmEng Technology, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmEng International, Inc., PharmEng Technology, Inc. is a full-service consulting firm that serves pharmaceutical, biotechnology, and medical device industries. The company is based in Toronto, Canada. PharmEng Technology prides itself on its proven track record of excellence which ensures that all client needs and governing regulatory expectations are met and exceeded. Since 1997, the Canadian company has provided industry-recognized services to assist clients in the rapid commercialization of new products from drug discovery to strategic planning to process scale up. The company was founded in 1977 by Alan Kwong. Alan Kwong has been the CEO since 1977. | Pharmaceuticals: Major | Corporate Officer/Principal | |
NeuroBioPharm, Inc.
 NeuroBioPharm, Inc. Pharmaceuticals: MajorHealth Technology Part of Neptune Wellness Solutions, Inc., NeuroBioPharm, Inc. is a Canadian company that engages in the research and development of novel proprietary active pharmaceutical ingredients for cognitive and neurological conditions. The company is based in Laval, Canada. NeuroBioPharm was acquired by Neptune Wellness Solutions, Inc. on February 20, 2015 for $0.22 million. | Pharmaceuticals: Major | Chief Executive Officer | |
| Technische Universität Wien | College/University | Doctorate Degree | |
| Banner Pharmacaps (Canada) Ltd. | Corporate Officer/Principal | ||
| Smartrix Technologies, Inc. | Corporate Officer/Principal | ||
| Draxis Pharma, Inc. | President | ||
BioResource, Inc.
 BioResource, Inc. Food RetailRetail Trade BioResource, Inc. is a private company that offers homeopathic-spagyric medications and complementary medicine products for licensed or certified health practitioners. The company is based in Cotati, CA. The company's products are produced at a GMP-certified facility and manufactured according to a unique spagyric processing method listed in the German Homeopathic Pharmacopeia (HAB) to ensure the highest standards of quality, safety, and efficacy. | Food Retail | Chief Executive Officer | |
| The Twinwest Political Action Committee | Director/Board Member | ||
| RELEVIUM TECHNOLOGIES INC. | Pharmaceuticals: Other | Chairman | |
| LIFEIST WELLNESS INC. | Other Consumer Services | Investor Relations Contact | |
Aronnax International, Inc.
 Aronnax International, Inc. BiotechnologyHealth Technology Aronnax International, Inc. provides pre-clinical drug discovery and development services. The company was founded in 2005 and is headquartered in Montreal, Canada. | Biotechnology | Corporate Officer/Principal | |
| NORTH BUD FARMS INC. | Pharmaceuticals: Major | Investor Relations Contact | |
Biocannabix Health Corp.
 Biocannabix Health Corp. Pharmaceuticals: MajorHealth Technology Biocannabix Health Corp. engages in developing pediatric endo-medicines. The company was founded on September 26, 2016 and is headquartered in Montreal, Canada. | Pharmaceuticals: Major | Director/Board Member | |
| GEEKCO TECHNOLOGIES CORPORATION | Advertising/Marketing Services | Director/Board Member | |
| Université du Québec à Montréal | College/University | Undergraduate Degree | |
Chartered Professional Accountants of Canada
 Chartered Professional Accountants of Canada Miscellaneous Commercial ServicesCommercial Services Chartered Professional Accountants of Canada (CPA) is a national accounting organization representing over 220,000 CPAs at national and international levels. The non-profit company is based in Toronto, Canada. CPA Canada collaborates with provincial and territorial regulatory bodies to support the profession and promote transparency in financial markets. The organization contributes to standard setting and public policy and works with international bodies to build a stronger accounting profession worldwide. CPA Canada provides extensive resources covering sustainability, corporate reporting, standards, and audit issues. The organization champions best practices that benefit business and society and prepares its members for an ever-evolving operating environment featuring unprecedented change. Pamela Steer has been the CEO of the Canadian company since 2022. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistik
International
| Kanada | 30 |
| Vereinigte Staaten | 13 |
| Vereinigtes Königreich | 3 |
| Deutschland | 2 |
| Österreich | 2 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Finance | 4 |
| Retail Trade | 3 |
Operativ
| Corporate Officer/Principal | 18 |
| Director/Board Member | 12 |
| President | 8 |
| Investor Relations Contact | 8 |
| Director of Finance/CFO | 6 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- John Durham
- Unternehmensverbindungen
